全球咽炎治疗市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球咽炎治疗市场 – 行业趋势及 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Pharyngitis Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 2.20 Billion
Diagram Market Size (Forecast Year)
USD 3.23 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球咽炎治疗市场,按药物类别(大环内酯类、β-内酰胺类、四环素类及其他)、给药方式(口服、静脉注射、肌肉注射及其他)、最终用户(医院、家庭护理、专科中心及其他)、分销渠道(医院药房、网上药房、零售药房)划分 - 行业趋势及预测至 2030 年。

咽炎治疗市场

咽炎治疗市场分析和规模

根据最近的研究,大约 70% 的呼吸道链球菌感染是无症状的,这些感染可引起严重的非支持性反应。咽炎最常见的原因是病毒感染,例如感冒、流感和单核细胞增多症。据观察,在不了解确切病因的情况下自行使用抗生素等治疗咽炎的药物会使病情恶化,并可能持续数天。

Data Bridge Market Research 分析了 2023-2030 年预测期内咽炎治疗市场的增长率。在上述预测期内,咽炎治疗市场的预期复合年增长率约为 4.9%。2022 年市场价值为 22 亿美元,到 2030 年将增长至 32.3 亿美元。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

咽炎治疗市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

药品类别(大环内酯类、β-内酰胺类、四环素类等)、给药方式(口服、静脉注射、肌肉注射等)、最终用户(医院、家庭护理、专科中心等)、分销渠道(医院药房、网上药房、零售药房)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

Bausch Health Companies Inc. (Canada.), Accord Healthcare (U.K.), Genentech, Inc (U.S.), PLIVA (Croatia), Pfizer Inc (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V. (U.S.), AbbVie Inc (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), ZAMBON COMPANY S.P.A (Italy)

Market Opportunities

Market Definition

Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes sneezing, headache, fatigue, runny nose, body aches, chills and others.

Global Pharyngitis Treatment Market Dynamics

Drivers

  • Increased Incidence of Pharyngitis

In 2020, more than 2.8 million people were reported to suffer from pharyngitis, with 1.1 million children under the age of 16. Pharyngitis is most common in kids under the age of 5 years. Adults also witness this condition but it develops slowly in them. Pharyngitis occurrences are quite high over the world, mainly in nations when antibiotics are extensively prescribed.

  • Growing Awareness about Viral Infections

The increasing awareness about several viral infections led to the growth of the market. Flu, AIDS, and Ebola virus public awareness campaigns are also a vital component in raising public knowledge and, consequently, affecting segment growth. The World Health Organization (WHO) advises countries to maintain routine viral disease surveillance, specimens from surveillance sites for viral diseases and launches various campaigns for the diseases.

Opportunities

  • Increase in GAS pharyngitis

As per the recent research, about 70% of streptococcal infections of the respiratory tract are non-symptomatic, and these infections can cause serious non-suppurative reaction. Even though acute pharyngitis is one of the most prevalent diseases among school-going children, GAS pharyngitis is uncommon. GAS pharyngitis and non-streptococcal pharyngitis have almost similar clinical appearances, making it difficult for physicians to differentiate between them without laboratory analysis.

  • Increasing Demand of Antiviral Drugs

Pharyngitis treatment market for antiviral drugs is estimated to dominate the market by the end of 2030 and the segment is expected to witness exponential growth rate during the forecast period 2022-2030. It has been witnessed that Amoxicillin and penicillin are the most commonly prescribed antibiotics for strep throat and are likely to uphold the market growth.

Restraints/Challenges

  • Lack of skilled professionals

缺乏合格的医疗专业人员进行治疗可能会在预测期内减少咽炎治疗市场的增长。

  • 咽炎治疗的副作用

治疗过程中产生的不良副作用阻碍了市场的增长。感染、瘙痒以及一些药物等副作用可能会导致严重的反应

本咽炎治疗市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关咽炎治疗市场的更多信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

全球咽炎治疗市场范围

咽炎治疗市场根据药物类别、给药方式、分销渠道和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

药物类别

  • 大环内酯类
  • β-内酰胺
  • 四环素
  • 其他的

交付方式

  • 口服
  • 静脉注射 肌肉注射
  • 其他的

最终用户

  • 医院
  • 家庭护理
  • 专业中心
  • 其他的

分销渠道

  • 医院药房
  • 网上药店
  • 零售药店

咽炎治疗市场区域分析/见解

对咽炎治疗市场进行了分析,并按上述药品类别、给药方式、分销渠道和最终用户提供了市场规模洞察和趋势。

咽炎治疗市场报告涉及的主要国家 有北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于产品主要制造商的存在以及不断增加的研发活动,北美预计将拥有最高的市场增长。

由于咽炎治疗市场的新研究和发展的增加,亚太地区占据了市场主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外,在提供国家数据预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和全球咽炎治疗市场份额分析

咽炎治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对咽炎治疗市场的关注有关。

咽炎治疗市场的主要参与者包括:

  • Bausch Health Companies Inc.(加拿大)
  • Accord Healthcare(英国)
  • 基因泰克公司(美国)
  • 普利瓦(克罗地亚)
  • 辉瑞公司 (美国)
  • Amneal Pharmaceuticals LLC.(美国)
  • 梯瓦制药工业有限公司 (以色列)
  • Mylan NV(美国)
  • AbbVie Inc(美国)
  • 葛兰素史克公司 (英国)
  • 诺华公司(瑞士)
  • ZAMBON COMPANY SPA(意大利)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Pharyngitis Treatment Market will be worth USD 3.23 billion by 2030
Pharyngitis Treatment Market growth rate is 4.9% during the forecast period.
Increased Incidence of Pharyngitis and Growing Awareness about Viral Infections are the growth drivers of the Pharyngitis Treatment Market.
Drug class, mode of delivery, distribution channel and end-user are the factors on which the Pharyngitis Treatment Market research is based.
Bausch Health Companies Inc. (Canada.), Accord Healthcare (U.K.), Genentech, Inc (U.S.), PLIVA (Croatia), Pfizer Inc (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Teva Pharmaceutical Industries Ltd (Israel), Mylan N.V. (U.S.), AbbVie Inc (U.S.) are the major companies in the Pharyngitis Treatment Market.